Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Increased gastric mucus secretion alleviates non-steroidal anti-inflammatory drug-induced abdominal pain.

Iwabuchi T, Iijima K, Ara N, Koike T, Shinkai H, Ichikawa T, Kamata Y, Ishihara K, Shimosegawa T.

Tohoku J Exp Med. 2013;231(1):29-36.

2.

Reactive increase in gastric mucus secretion is an adaptive defense mechanism against low-dose aspirin-induced gastropathy.

Iijima K, Iwabuchi T, Ara N, Koike T, Shinkai H, Kamata Y, Ichikawa T, Ishihara K, Shimosegawa T.

Dig Dis Sci. 2013 Aug;58(8):2266-74. doi: 10.1007/s10620-013-2660-7. Epub 2013 May 7.

PMID:
23649375
3.

A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production.

Laine L, Sloane R, Ferretti M, Cominelli F.

Gastrointest Endosc. 1995 Nov;42(5):428-33.

PMID:
8566633
4.
5.

Gastric mucosal adaptation to etodolac and naproxen.

Lipscomb GR, Wallis N, Armstrong G, Goodman MJ, Rees WD.

Aliment Pharmacol Ther. 1995 Aug;9(4):379-85.

PMID:
8527613
7.

Restorative impact of rabeprazole on gastric mucus and mucin production impairment during naproxen administration: its potential clinical significance.

Jaworski T, Sarosiek I, Sostarich S, Roeser K, Connor M, Brotze S, Wallner G, Sarosiek J.

Dig Dis Sci. 2005 Feb;50(2):357-65.

PMID:
15745101
8.

Association of gastric acid and mucus secretion level with low-dose aspirin-induced gastropathy.

Iijima K, Ara N, Abe Y, Koike T, Iwai W, Iwabuchi T, Ichikawa T, Kamata Y, Ishihara K, Shimosegawa T.

J Gastroenterol. 2012 Feb;47(2):150-8. doi: 10.1007/s00535-011-0478-7. Epub 2011 Oct 27.

PMID:
22038552
11.

Non-steroidal anti-inflammatory drug gastropathy: causes and treatment.

Hawkey CJ.

Scand J Gastroenterol Suppl. 1996;220:124-7. Review.

PMID:
8898449
12.

Gastroprotective and ulcer healing effects of nitric oxide-releasing non-steroidal anti-inflammatory drugs.

Brzozowski T, Konturek PC, Konturek SJ, Sliwowski Z, Drozdowicz D, KwiecieĊ„ S, Pajdo R, Ptak A, Pawlik M, Hahn E.

Dig Liver Dis. 2000 Oct;32(7):583-94.

PMID:
11142556
13.

Etodolac, a new nonsteroidal anti-inflammatory drug: gastrointestinal microbleeding and endoscopic studies.

Lanza FL, Arnold JD.

Clin Rheumatol. 1989 Mar;8 Suppl 1:5-15. Review.

PMID:
2525983
14.
16.

Interaction of NSAIDs and Helicobacter pylori on gastrointestinal injury and prostaglandin production: a controlled double-blind trial.

Laine L, Cominelli F, Sloane R, Casini-Raggi V, Marin-Sorensen M, Weinstein WM.

Aliment Pharmacol Ther. 1995 Apr;9(2):127-35.

PMID:
7605852
17.
19.

The effect of non-steroidal anti-inflammatory drugs and Helicobacter pylori infection on the gastric mucosa in children with upper gastrointestinal bleeding.

Boukthir S, Mazigh SM, Kalach N, Bouyahya O, Sammoud A.

Pediatr Surg Int. 2010 Feb;26(2):227-30. doi: 10.1007/s00383-009-2492-x. Epub 2009 Oct 13. Erratum in: Pediatr Surg Int. 2010 Feb;26(2):231. Kaach, Nicolas [corrected to Kalach, Nicolas].

PMID:
19823852
20.

Gastric mucosal injury and adaptation to oral and rectal administration of naproxen.

Lipscomb GR, Rees WD.

Aliment Pharmacol Ther. 1996 Apr;10(2):133-8.

PMID:
8730240

Supplemental Content

Support Center